Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy

BACKGROUND: Glycemic control is suboptimal in many individuals with type 2 diabetes. Although use of flash continuous glucose monitoring (CGM) has demonstrated A1C reductions in patients with type 2 diabetes treated with a multiple daily injection or insulin pump therapy regimen, the glycemic benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Eugene E., Kerr, Matthew S.D., Reyes, Ignacio J., Nabutovsky, Yelena, Miller, Eden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178717/
https://www.ncbi.nlm.nih.gov/pubmed/34149259
http://dx.doi.org/10.2337/ds20-0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178717/
https://www.ncbi.nlm.nih.gov/pubmed/34149259
http://dx.doi.org/10.2337/ds20-0069

Ejemplares similares